Illumina offers contract to customers for 12-year supply with guarantees of continued supply, no price increases
MLex Summary: To allay concerns regarding its acquisition of Grail, Illumina said it is offering new and existing US oncology customers a 12-year supply contract for its sequencing products and support...To view the full article, register now.
Already a subscriber? Click here to view full article